Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
{
"resourceType" : "CodeSystem",
"id" : "sha-interventions-cs",
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem sha-interventions-cs</b></p><a name=\"sha-interventions-cs\"> </a><a name=\"hcsha-interventions-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">SHA-CHEMO-FIRST-LINE<a name=\"sha-interventions-cs-SHA-CHEMO-FIRST-LINE\"> </a></td><td>SHA: Chemotherapy — First Line</td><td>First-line chemotherapy regimen.</td></tr><tr><td style=\"white-space:nowrap\">SHA-CHEMO-SECOND-LINE<a name=\"sha-interventions-cs-SHA-CHEMO-SECOND-LINE\"> </a></td><td>SHA: Chemotherapy — Second Line</td><td>Second-line or salvage chemotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-CHEMO-ADJUVANT<a name=\"sha-interventions-cs-SHA-CHEMO-ADJUVANT\"> </a></td><td>SHA: Chemotherapy — Adjuvant</td><td>Post-surgery adjuvant chemotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-CHEMO-NEO-ADJUVANT<a name=\"sha-interventions-cs-SHA-CHEMO-NEO-ADJUVANT\"> </a></td><td>SHA: Chemotherapy — Neo-adjuvant</td><td>Pre-surgery neo-adjuvant chemotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-CHEMO-PALLIATIVE<a name=\"sha-interventions-cs-SHA-CHEMO-PALLIATIVE\"> </a></td><td>SHA: Chemotherapy — Palliative</td><td>Palliative intent chemotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-RADICAL<a name=\"sha-interventions-cs-SHA-RT-RADICAL\"> </a></td><td>SHA: Radiotherapy — Radical</td><td>Curative radiotherapy course.</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-PALLIATIVE<a name=\"sha-interventions-cs-SHA-RT-PALLIATIVE\"> </a></td><td>SHA: Radiotherapy — Palliative</td><td>Palliative radiotherapy course.</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-ADJUVANT<a name=\"sha-interventions-cs-SHA-RT-ADJUVANT\"> </a></td><td>SHA: Radiotherapy — Adjuvant</td><td>Post-surgery adjuvant radiotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-CONCURRENT-CRT<a name=\"sha-interventions-cs-SHA-RT-CONCURRENT-CRT\"> </a></td><td>SHA: Concurrent Chemo-Radiotherapy</td><td>Chemotherapy and radiotherapy delivered concurrently.</td></tr><tr><td style=\"white-space:nowrap\">SHA-SURGERY-CURATIVE<a name=\"sha-interventions-cs-SHA-SURGERY-CURATIVE\"> </a></td><td>SHA: Surgery — Curative</td><td>Cancer surgery with curative intent.</td></tr><tr><td style=\"white-space:nowrap\">SHA-SURGERY-PALLIATIVE<a name=\"sha-interventions-cs-SHA-SURGERY-PALLIATIVE\"> </a></td><td>SHA: Surgery — Palliative</td><td>Palliative or debulking surgery.</td></tr><tr><td style=\"white-space:nowrap\">SHA-BMT-AUTOLOGOUS<a name=\"sha-interventions-cs-SHA-BMT-AUTOLOGOUS\"> </a></td><td>SHA: BMT — Autologous</td><td>Autologous bone marrow / stem cell transplant.</td></tr><tr><td style=\"white-space:nowrap\">SHA-BMT-ALLOGENEIC<a name=\"sha-interventions-cs-SHA-BMT-ALLOGENEIC\"> </a></td><td>SHA: BMT — Allogeneic</td><td>Allogeneic bone marrow / stem cell transplant.</td></tr><tr><td style=\"white-space:nowrap\">SHA-HORMONAL-THERAPY<a name=\"sha-interventions-cs-SHA-HORMONAL-THERAPY\"> </a></td><td>SHA: Hormonal Therapy</td><td>Hormone therapy for hormone-responsive cancers.</td></tr><tr><td style=\"white-space:nowrap\">SHA-TARGETED-THERAPY<a name=\"sha-interventions-cs-SHA-TARGETED-THERAPY\"> </a></td><td>SHA: Targeted Therapy</td><td>Targeted molecular therapy / immunotherapy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-SUPPORTIVE-CARE<a name=\"sha-interventions-cs-SHA-SUPPORTIVE-CARE\"> </a></td><td>SHA: Supportive / Supportive Care</td><td>Supportive medications and G-CSF.</td></tr><tr><td style=\"white-space:nowrap\">SHA-PAIN-MANAGEMENT<a name=\"sha-interventions-cs-SHA-PAIN-MANAGEMENT\"> </a></td><td>SHA: Palliative Pain Management</td><td>Opioid and pain management for cancer.</td></tr><tr><td style=\"white-space:nowrap\">SHA-CANCER-SCREENING<a name=\"sha-interventions-cs-SHA-CANCER-SCREENING\"> </a></td><td>SHA: Cancer Screening</td><td>Covered cancer screening tests (cervical, breast).</td></tr><tr><td style=\"white-space:nowrap\">SHA-BIOPSY<a name=\"sha-interventions-cs-SHA-BIOPSY\"> </a></td><td>SHA: Diagnostic Biopsy</td><td>Tissue biopsy for cancer diagnosis.</td></tr><tr><td style=\"white-space:nowrap\">SHA-IMAGING<a name=\"sha-interventions-cs-SHA-IMAGING\"> </a></td><td>SHA: Oncology Diagnostic Imaging</td><td>CT, MRI, PET-CT for staging or response.</td></tr><tr><td style=\"white-space:nowrap\">SHA-ONCOLOGY-CONSULT<a name=\"sha-interventions-cs-SHA-ONCOLOGY-CONSULT\"> </a></td><td>SHA: Oncology Consultation</td><td>Specialist oncology consultation.</td></tr><tr><td style=\"white-space:nowrap\">SHA-MDT<a name=\"sha-interventions-cs-SHA-MDT\"> </a></td><td>SHA: MDT Meeting</td><td>Multidisciplinary tumour board review.</td></tr><tr><td style=\"white-space:nowrap\">SHA-PATHOLOGY<a name=\"sha-interventions-cs-SHA-PATHOLOGY\"> </a></td><td>SHA: Pathology / Histopathology</td><td>Histopathology, IHC, or molecular diagnostics.</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-DOSE-PER-FRACTION<a name=\"sha-interventions-cs-SHA-RT-DOSE-PER-FRACTION\"> </a></td><td>SHA: RT Dose Per Fraction</td><td>Radiation dose delivered per fraction (Gy).</td></tr><tr><td style=\"white-space:nowrap\">SHA-RT-TOTAL-FRACTIONS<a name=\"sha-interventions-cs-SHA-RT-TOTAL-FRACTIONS\"> </a></td><td>SHA: RT Total Fractions Delivered</td><td>Total number of radiation fractions delivered.</td></tr><tr><td style=\"white-space:nowrap\">SHA-SUSPECTED-CANCER-TYPE<a name=\"sha-interventions-cs-SHA-SUSPECTED-CANCER-TYPE\"> </a></td><td>SHA: Suspected Cancer Type</td><td>Type of cancer suspected at screening/referral.</td></tr><tr><td style=\"white-space:nowrap\">SHA-SUSPICION-LEVEL<a name=\"sha-interventions-cs-SHA-SUSPICION-LEVEL\"> </a></td><td>SHA: Cancer Suspicion Level</td><td>Clinical level of suspicion for malignancy.</td></tr><tr><td style=\"white-space:nowrap\">SHA-REASON-FOR-SUSPICION<a name=\"sha-interventions-cs-SHA-REASON-FOR-SUSPICION\"> </a></td><td>SHA: Reason for Suspicion</td><td>Reason underpinning the cancer suspicion.</td></tr><tr><td style=\"white-space:nowrap\">SHA-PRESENTING-SYMPTOMS<a name=\"sha-interventions-cs-SHA-PRESENTING-SYMPTOMS\"> </a></td><td>SHA: Presenting Symptoms</td><td>Symptoms presented by the patient.</td></tr><tr><td style=\"white-space:nowrap\">SHA-DIAGNOSTIC-WORKUP<a name=\"sha-interventions-cs-SHA-DIAGNOSTIC-WORKUP\"> </a></td><td>SHA: Planned Diagnostic Workup</td><td>Diagnostic investigations planned for confirmation.</td></tr></table></div>"
},
"url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
"version" : "0.1.0",
"name" : "SHAInterventionsCS",
"title" : "Kenya SHA Oncology Interventions Code System",
"status" : "active",
"experimental" : false,
"date" : "2026-06-04T14:49:30+00:00",
"publisher" : "Digital Health Agency (DHA), Kenya",
"contact" : [
{
"name" : "Digital Health Agency (DHA), Kenya",
"telecom" : [
{
"system" : "url",
"value" : "https://dha.go.ke"
},
{
"system" : "email",
"value" : "info@dha.go.ke"
}
]
},
{
"name" : "Digital Health Agency Kenya – FHIR Team",
"telecom" : [
{
"system" : "email",
"value" : "info@dha.go.ke",
"use" : "work"
},
{
"system" : "url",
"value" : "https://dha.go.ke",
"use" : "work"
}
]
}
],
"description" : "Social Health Authority (SHA) benefit package codes for oncology interventions.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "KE",
"display" : "Kenya"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 30,
"concept" : [
{
"code" : "SHA-CHEMO-FIRST-LINE",
"display" : "SHA: Chemotherapy — First Line",
"definition" : "First-line chemotherapy regimen."
},
{
"code" : "SHA-CHEMO-SECOND-LINE",
"display" : "SHA: Chemotherapy — Second Line",
"definition" : "Second-line or salvage chemotherapy."
},
{
"code" : "SHA-CHEMO-ADJUVANT",
"display" : "SHA: Chemotherapy — Adjuvant",
"definition" : "Post-surgery adjuvant chemotherapy."
},
{
"code" : "SHA-CHEMO-NEO-ADJUVANT",
"display" : "SHA: Chemotherapy — Neo-adjuvant",
"definition" : "Pre-surgery neo-adjuvant chemotherapy."
},
{
"code" : "SHA-CHEMO-PALLIATIVE",
"display" : "SHA: Chemotherapy — Palliative",
"definition" : "Palliative intent chemotherapy."
},
{
"code" : "SHA-RT-RADICAL",
"display" : "SHA: Radiotherapy — Radical",
"definition" : "Curative radiotherapy course."
},
{
"code" : "SHA-RT-PALLIATIVE",
"display" : "SHA: Radiotherapy — Palliative",
"definition" : "Palliative radiotherapy course."
},
{
"code" : "SHA-RT-ADJUVANT",
"display" : "SHA: Radiotherapy — Adjuvant",
"definition" : "Post-surgery adjuvant radiotherapy."
},
{
"code" : "SHA-RT-CONCURRENT-CRT",
"display" : "SHA: Concurrent Chemo-Radiotherapy",
"definition" : "Chemotherapy and radiotherapy delivered concurrently."
},
{
"code" : "SHA-SURGERY-CURATIVE",
"display" : "SHA: Surgery — Curative",
"definition" : "Cancer surgery with curative intent."
},
{
"code" : "SHA-SURGERY-PALLIATIVE",
"display" : "SHA: Surgery — Palliative",
"definition" : "Palliative or debulking surgery."
},
{
"code" : "SHA-BMT-AUTOLOGOUS",
"display" : "SHA: BMT — Autologous",
"definition" : "Autologous bone marrow / stem cell transplant."
},
{
"code" : "SHA-BMT-ALLOGENEIC",
"display" : "SHA: BMT — Allogeneic",
"definition" : "Allogeneic bone marrow / stem cell transplant."
},
{
"code" : "SHA-HORMONAL-THERAPY",
"display" : "SHA: Hormonal Therapy",
"definition" : "Hormone therapy for hormone-responsive cancers."
},
{
"code" : "SHA-TARGETED-THERAPY",
"display" : "SHA: Targeted Therapy",
"definition" : "Targeted molecular therapy / immunotherapy."
},
{
"code" : "SHA-SUPPORTIVE-CARE",
"display" : "SHA: Supportive / Supportive Care",
"definition" : "Supportive medications and G-CSF."
},
{
"code" : "SHA-PAIN-MANAGEMENT",
"display" : "SHA: Palliative Pain Management",
"definition" : "Opioid and pain management for cancer."
},
{
"code" : "SHA-CANCER-SCREENING",
"display" : "SHA: Cancer Screening",
"definition" : "Covered cancer screening tests (cervical, breast)."
},
{
"code" : "SHA-BIOPSY",
"display" : "SHA: Diagnostic Biopsy",
"definition" : "Tissue biopsy for cancer diagnosis."
},
{
"code" : "SHA-IMAGING",
"display" : "SHA: Oncology Diagnostic Imaging",
"definition" : "CT, MRI, PET-CT for staging or response."
},
{
"code" : "SHA-ONCOLOGY-CONSULT",
"display" : "SHA: Oncology Consultation",
"definition" : "Specialist oncology consultation."
},
{
"code" : "SHA-MDT",
"display" : "SHA: MDT Meeting",
"definition" : "Multidisciplinary tumour board review."
},
{
"code" : "SHA-PATHOLOGY",
"display" : "SHA: Pathology / Histopathology",
"definition" : "Histopathology, IHC, or molecular diagnostics."
},
{
"code" : "SHA-RT-DOSE-PER-FRACTION",
"display" : "SHA: RT Dose Per Fraction",
"definition" : "Radiation dose delivered per fraction (Gy)."
},
{
"code" : "SHA-RT-TOTAL-FRACTIONS",
"display" : "SHA: RT Total Fractions Delivered",
"definition" : "Total number of radiation fractions delivered."
},
{
"code" : "SHA-SUSPECTED-CANCER-TYPE",
"display" : "SHA: Suspected Cancer Type",
"definition" : "Type of cancer suspected at screening/referral."
},
{
"code" : "SHA-SUSPICION-LEVEL",
"display" : "SHA: Cancer Suspicion Level",
"definition" : "Clinical level of suspicion for malignancy."
},
{
"code" : "SHA-REASON-FOR-SUSPICION",
"display" : "SHA: Reason for Suspicion",
"definition" : "Reason underpinning the cancer suspicion."
},
{
"code" : "SHA-PRESENTING-SYMPTOMS",
"display" : "SHA: Presenting Symptoms",
"definition" : "Symptoms presented by the patient."
},
{
"code" : "SHA-DIAGNOSTIC-WORKUP",
"display" : "SHA: Planned Diagnostic Workup",
"definition" : "Diagnostic investigations planned for confirmation."
}
]
}